Science Market Update

OHSU Gets New NIH Science Research Funding for Cardiac Arrest Study

Posted by Dylan Fitzwater on Tue, Jul 31, 2012

Oregon Health and Science University (OHSU) recently received $245,115 in new NIH science research funding for a study of the effectiveness of two drugs commonly used to restore heart function in cardiac arrest victims. Researchers will be determining whether the drugs Amiodarone and Lidocaine actually improve cardiac arrest patients' chance of survival, and if so which is more effective. These drugs are both used to restore the loss of rhythmic and regular heartbeats that is a common cause of cardiac arrest, though their overall effectiveness at improving survival among patients has not been well documented. Typically first responders pick one or the other, but their decisions are not based on hard comparative evidence of the drugs' benefits.

Read More

Tags: Northeast, Oregon Health Sciences University, Oregon, 2012, Cardiac Arrest, Front Line event, NIH, OR, OHSU, Portland, BRPF

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News